Literature DB >> 1626069

Use of human data in quantitative risk assessment of carcinogens: impact on epidemiologic practice and the regulatory process.

R E Shore1, V Iyer, B Altshuler, B S Pasternack.   

Abstract

Epidemiologic data are increasingly being used to assess cancer risk from chemicals as their value is recognized and as more and better studies become available. Weight-of-evidence approaches are now available for classifying the experimental and epidemiological evidence regarding human carcinogenicity. When the human data are extensive and of good quality, they should be given substantial weight in assessing risk. Both the positive and the negative epidemiologic data should be used in a quantitative risk assessment (QRA), because only then can an unbiased risk assessment be derived. Good-quality epidemiological studies are those with sound methodology, lack of bias, long enough follow-up times to observe a carcinogenic response, adequate exposure information, and dose-response information. Before a lack of carcinogenicity can be inferred, it is essential that the exposures be of substantial duration and intensity, and that the number of exposed persons be reasonably large. Epidemiologists need to give more attention to exposure assessment, because lack of quantitative exposure information is often the limiting factor that prevents the use of epidemiologic data in QRA. Development of methods to estimate historical workplace exposure intensities from surrogate industrial hygiene variables should receive high research priority, since they have the potential to increase the usefulness in QRA of many epidemiologic studies that have limited exposure information. Several frequently used surrogates for exposure measurements have limitations or pitfalls in their use. In particular, the use of "ever/never" exposed has a large potential to produce falsely negative results by means of a "dilution" effect, especially in the common case where the exposure distribution is skewed. Duration of exposure (rather than duration x intensity) may also give misleading results. There is little information to suggest that synergistic exposures to multiple toxicants in an industrial environment are likely to invalidate QRAs, probably because few studies have identified a group of workers with major workplace exposures to multiple carcinogens that cause the same type of cancer. Most of the interactive effects which have been identified to date are between smoking and some occupational carcinogen, so this possibility needs careful evaluation for smoking-related diseases. It is important to evaluate dose-response gradients in a QRA to obtain maximum precision and accuracy in the resulting risk coefficient. The analysis should take into account an appropriate cancer induction period. Various methods to account for cancer induction times are compared; those that incorporate a lag period or model the induction-time distribution are superior to other methods.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626069     DOI: 10.1016/0273-2300(92)90049-f

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  10 in total

1.  Epidemiologic data in risk assessment--imperfect but valuable.

Authors:  R E Shore
Journal:  Am J Public Health       Date:  1995-04       Impact factor: 9.308

2.  Comment: integrating epidemiologic data into risk assessment.

Authors:  D Wartenberg; R Simon
Journal:  Am J Public Health       Date:  1995-04       Impact factor: 9.308

3.  Epidemiology and quantitative risk assessment: a bridge from science to policy.

Authors:  I Hertz-Picciotto
Journal:  Am J Public Health       Date:  1995-04       Impact factor: 9.308

Review 4.  Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses.

Authors:  A Monro
Journal:  J Pharmacokinet Biopharm       Date:  1994-02

5.  But other than mesothelioma? An estimate of the proportion of work-related cancers in Quebec.

Authors:  F Labrèche; P Duguay; A Boucher; R Arcand
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

6.  Ethylene oxide: an assessment of the epidemiological evidence on carcinogenicity.

Authors:  R E Shore; M J Gardner; B Pannett
Journal:  Br J Ind Med       Date:  1993-11

7.  Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data.

Authors:  Karen H Watanabe; Mirjana V Djordjevic; Steven D Stellman; Patricia L Toccalino; Donald F Austin; James F Pankow
Journal:  Regul Toxicol Pharmacol       Date:  2009-06-18       Impact factor: 3.271

Review 8.  An alternative approach for investigating the carcinogenicity of indoor air pollution: pets as sentinels of environmental cancer risk.

Authors:  J A Bukowski; D Wartenberg
Journal:  Environ Health Perspect       Date:  1997-12       Impact factor: 9.031

9.  Guidelines to evaluate human observational studies for quantitative risk assessment.

Authors:  Jelle Vlaanderen; Roel Vermeulen; Dick Heederik; Hans Kromhout
Journal:  Environ Health Perspect       Date:  2008-08-12       Impact factor: 9.031

Review 10.  Cancer risk assessment of extremely low frequency electric and magnetic fields: a critical review of methodology.

Authors:  J McCann
Journal:  Environ Health Perspect       Date:  1998-11       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.